Invention Grant
- Patent Title: Pyrido-pyrimidine derivatives
- Patent Title (中): 吡啶并嘧啶衍生物
-
Application No.: US14234356Application Date: 2012-06-15
-
Publication No.: US09283225B2Publication Date: 2016-03-15
- Inventor: Wolfgang Staehle , Oliver Schadt , Christine Knuehl , Manja Friese-Hamim , Bayard R. Huck , Andreas Goutopoulos , Nadia Brugger
- Applicant: Wolfgang Staehle , Oliver Schadt , Christine Knuehl , Manja Friese-Hamim , Bayard R. Huck , Andreas Goutopoulos , Nadia Brugger
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Merck Patent GmbH
- International Application: PCT/US2012/042567 WO 20120615
- International Announcement: WO2013/022519 WO 20130214
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61K45/06 ; C07D471/04 ; A61P35/00 ; A61P37/00 ; A61P9/10 ; A61P25/28 ; A61P27/06
Abstract:
Compounds of the formula I in which Het, R3 and R4 have the meanings indicated in Claim 1, are inhibitors of RON and can be employed, for the treatment of cancer.
Public/Granted literature
- US20140228379A1 Pyrido-Pyrimidine Derivatives Public/Granted day:2014-08-14
Information query
